296 related articles for article (PubMed ID: 18760193)
1. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.
López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Rocha-Moreno YG; Gascón-Lastiri G; Rivera-Márquez H; Wanzke-del-Angel V; Cerecedo-Díaz F; de la Cruz-Yañez H
Arch Med Res; 2008 Oct; 39(7):655-62. PubMed ID: 18760193
[TBL] [Abstract][Full Text] [Related]
2. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
MacDonald TJ; Arenson EB; Ater J; Sposto R; Bevan HE; Bruner J; Deutsch M; Kurczynski E; Luerssen T; McGuire-Cullen P; O'Brien R; Shah N; Steinbok P; Strain J; Thomson J; Holmes E; Vezina G; Yates A; Phillips P; Packer R
Cancer; 2005 Dec; 104(12):2862-71. PubMed ID: 16315242
[TBL] [Abstract][Full Text] [Related]
4. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
[TBL] [Abstract][Full Text] [Related]
6. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
8. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy.
Lopez-Aguilar E; Sepulveda-Vildosola AC; Rivera-Marquez H; Cerecedo-Diaz F; Santacruz-Castillo E; Valdez-Sanchez M; Arias-Gomez J; Quintana-Roldan G
Arch Med Res; 1998; 29(4):313-7. PubMed ID: 9887549
[TBL] [Abstract][Full Text] [Related]
10. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
[TBL] [Abstract][Full Text] [Related]
11. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
[TBL] [Abstract][Full Text] [Related]
13. Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.
Chintagumpala M; Blaney SM; Bomgaars LR; Aleksic A; Kuttesch JF; Klenke RA; Berg SL
J Clin Oncol; 2004 Nov; 22(21):4394-400. PubMed ID: 15514381
[TBL] [Abstract][Full Text] [Related]
14. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Sep; 104(6):1281-7. PubMed ID: 16078267
[TBL] [Abstract][Full Text] [Related]
15. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
16. Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01.
Fousseyni T; Diawara M; Pasquier E; André N
J Pediatr Hematol Oncol; 2011 Jan; 33(1):31-4. PubMed ID: 21164360
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.
Ziegler DS; Cohn RJ; McCowage G; Alvaro F; Oswald C; Mrongovius R; White L;
Neuro Oncol; 2006 Jan; 8(1):53-9. PubMed ID: 16443948
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
[TBL] [Abstract][Full Text] [Related]
19. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
Gilheeney SW; Lyden DC; Sgouros S; Antunes N; Gerald W; Kramer K; Lis E; Meyers P; Rosen N; Thaler HT; Trippett T; Wexler L; Dunkel IJ
Pediatr Blood Cancer; 2007 Sep; 49(3):261-5. PubMed ID: 16972243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
